T Rowe Price Health Sciences F's ticker is and the CUSIP is 741480107. A total of 3 filers reported holding T Rowe Price Health Sciences F in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $264,000 | +6.9% | 2,840 | 0.0% | 0.08% | -2.6% |
| Q2 2020 | $247,000 | +23.5% | 2,840 | 0.0% | 0.08% | +4.0% |
| Q1 2020 | $200,000 | -13.4% | 2,840 | 0.0% | 0.08% | +13.6% |
| Q4 2019 | $231,000 | -8.0% | 2,840 | -17.9% | 0.07% | -13.2% |
| Q3 2019 | $251,000 | -7.7% | 3,459 | 0.0% | 0.08% | -1.3% |
| Q2 2019 | $272,000 | +1.5% | 3,459 | 0.0% | 0.08% | +2.7% |
| Q1 2019 | $268,000 | -39.4% | 3,459 | -47.5% | 0.08% | +7.1% |
| Q4 2018 | $442,000 | – | 6,593 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Westside Investment Management, Inc. | 1,467 | $130,645 | 0.32% |
| Coston, McIsaac & Partners | 806 | $72 | 0.03% |
| GOFEN & GLOSSBERG LLC /IL/ | 6,005 | $539 | 0.01% |
| DIVIDEND ASSETS CAPITAL, LLC | 460 | $41 | 0.01% |